{
    "text": "PD-L1 immunohistochemical assessment may be used for the selection of patients legible for treatment with anti-PD-L1 therapy in non-small cell lung cancer.", 
    "denotations": [
        {
            "id": "T1", 
            "obj": "gene", 
            "span": {
                "begin": 0, 
                "end": 5
            }
        }, 
        {
            "id": "T2", 
            "obj": "disease", 
            "span": {
                "begin": 128, 
                "end": 154
            }
        }
    ], 
    "relations": [
        {
            "id": "R1", 
            "pred": "prognostic", 
            "subj": "T2", 
            "obj": "T1"
        }
    ]
}